Cited by 65Amyotrophic Lateral Sclerosis ResearchNF-κB Signaling PathwaysGenetic Neurodegenerative Diseases

Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells

Open access
Picher-Martel, Vincent, Dutta, Kallol, Phaneuf, Daniel, Sobue, Gen, Julien, Jean-Pierre·2015·Molecular Brain

Abstract

BACKGROUND: Mutations in the gene encoding Ubiquilin-2 (UBQLN2) are linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). UBQLN2 plays a central role in ubiquitin proteasome system (UPS) and UBQLN2 mutants can form cytoplasmic aggregates in vitro and in vivo. RESULTS: Here, we report that overexpression of WT or mutant UBQLN2 species enhanced nuclear factor κB (NF-κB) activation in Neuro2A cells. The inhibition of NF-κB stress-mediated activation with SB203580, a p38 MAPK inhibitor, demonstrated a role for MAPK in NF-κB activation by UBQLN2 species. Live cell imaging and microscopy showed that UBQLN2 aggregates are dynamic structures that promote cytoplasmic accumulation of TAR DNA-binding protein (TDP-43), a major component of ALS inclusion bodies. Furthermore, up-regulation of UBQLN2 species in neurons caused an ER-stress response and increased their vulnerability to death by toxic mediator TNF-α. Withaferin A, a known NF-κB inhibitor, reduced mortality of Neuro2A cells overexpressing UBQLN2 species. CONCLUSIONS: These results suggest that UBQLN2 dysregulation in neurons can drive NF-κB activation and cytosolic TDP-43 aggregation, supporting the concept of pathway convergence in ALS pathogenesis. These Ubiquilin-2 pathogenic pathways might represent suitable therapeutic targets for future ALS treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13041-015-0162-6

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Overexpression of ALS-linked UBQLN2 mutants triggers intracellular inclusions and motor defects in vitro and in vivo.

    “while also triggering intracellular inclusions [226,227] and motor defects in vitro and in vivo [226].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Picher-Martel, V., Dutta, K., Phaneuf, D., Sobue, G., & Julien, J.-P.
Affiliations
  • Institut Universitaire en Santé Mentale de Québec (CA)
  • Nagoya University (JP)
Corresponding author
Julien, Jean-Pierre
Venue
Molecular Brain
Published
2015-10-31
Volume
8
Issue
1
Pages
71-71
ISSN
1756-6606 (ISSN-L)
OpenAlex
W1944550035
Cited by
65
References
53
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 14 · 2020: 11 · 2019: 10 · 2018: 7 · 2017: 3 · 2016: 2
FWCI
2.82
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Brain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (MOP119173)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
UBQLN2, NF-κB activation, TDP-43 aggregation, amyotrophic lateral sclerosis, frontotemporal dementia, ER stress response, p38 MAPK, withaferin A, neurodegeneration, protein aggregation, ubiquitin-proteasome system
MeSH terms
Autophagy-Related Proteins, NF-KappaB Inhibitor alpha, Amyotrophic Lateral Sclerosis, Animals, Inclusion Bodies, Cytosol, DNA-Binding Proteins, Humans, Neurons, Stress, Physiological, Ubiquitins, Up-Regulation, NF-kappa B, Cell Death, Cell Cycle Proteins, I-kappa B Proteins, MAP Kinase Signaling System, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Mice, Transcription Factor RelA, Endoplasmic Reticulum Stress, Protein Aggregates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review